Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Randomized, phase II trial comparing amrubicin with topotecan in patients (pts) with previously treated small cell lung cancer (SCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8042 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8042-8042 ◽

Cited By ~ 1

Author(s):

S. Sugawara ◽

A. Inoue ◽

K. Yamazaki ◽

Y. Saijo ◽

K. Gomi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

1332P A randomized phase II trial of standard versus low-dose nab-paclitaxel for previously treated advanced non-small cell lung cancer (JMTO LC14-01)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1933 ◽

2021 ◽

Vol 32 ◽

pp. S1019

Author(s):

S. Takeuchi ◽

S. Sugawara ◽

S. Teramukai ◽

R. Noro ◽

K. Fujikawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Randomized Phase II Trial of Standard Versus Low-Dose Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: JMTO LC14-01

SSRN Electronic Journal ◽

10.2139/ssrn.3971549 ◽

2021 ◽

Author(s):

Susumu Takeuchi ◽

Kaoru Kubota ◽

Shunichi Sugawara ◽

Satoshi Teramukai ◽

Rintaro Noro ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

P3-098: Multicenter, randomized phase II trial of CI–1033, an irreversible pan– erbB inhibitor, for previously treated advanced non–small cell lung cancer

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284074.65676.00 ◽

2007 ◽

Vol 2 (8) ◽

pp. S721

Author(s):

Pasi A. Janne ◽

Joachim von Pawel ◽

Roger B. Cohen ◽

Lucio Crino ◽

Charles A. Butts ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Phase Ii ◽

Randomized Phase II Trial of Sequential Chemotherapy in Advanced Non-Small Cell Lung Cancer (SWOG 9806)

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0002 ◽

2004 ◽

Vol 10 (15) ◽

pp. 5022-5026 ◽

Cited By ~ 40

Author(s):

Martin J. Edelman ◽

Joseph I. Clark ◽

Kari Chansky ◽

Kathy Albain ◽

Nirmala Bhoopalam ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Sequential Chemotherapy ◽

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-2968-z ◽

2016 ◽

Vol 77 (3) ◽

pp. 539-548 ◽

Cited By ~ 7

Author(s):

Su Jin Heo ◽

Inkyung Jung ◽

Choong-kun Lee ◽

Jee Hung Kim ◽

Sun Min Lim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Mrna Expression ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90806-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S235

Author(s):

J. Iglesias ◽

C. Crombie ◽

W.I. Burns ◽

C. Karapetis ◽

R.M. Lowenthal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

A Randomized Phase II Trial Using Two Different Treatment Schedules of Gemcitabine and Carboplatin in Patients with Advanced Non???Small-Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/01243894-200601000-00006 ◽

2006 ◽

Vol 1 (1) ◽

pp. 19-24 ◽

Cited By ~ 5

Author(s):

Gregory A. Masters ◽

Athanassios E. Argiris ◽

Elizabeth A. Hahn ◽

J Thaddeus Beck ◽

P Gregory Rausch ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0496-6 ◽

2007 ◽

Vol 61 (3) ◽

pp. 503-508 ◽

Cited By ~ 11

Author(s):

Fumiyoshi Ohyanagi ◽

Atsushi Horiike ◽

Yoshio Okano ◽

Yukitoshi Satoh ◽

Sakae Okumura ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Previously Treated Patients ◽

Gemcitabine Plus Vinorelbine as Second-line Chemotherapy of the Patients of Previously Treated Non-small Cell lung Cancer: Phase II Trial

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.4.344 ◽

2005 ◽

Vol 58 (4) ◽

pp. 344

Author(s):

Pil Soon Jang ◽

Hyun Mo Kang ◽

Jeong Eun Lee ◽

Seon Jung Kwon ◽

Jin Young An ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Previously Treated ◽

Line Chemotherapy